CompoAtlas

VERALAC

Natural health product licensed in Canada

Licence holder
Bausch Health, Canada Inc.
NPN or DIN-HM
80033844
Status
Inactive licence
Licence date
23 July 2012
Revision date
28 June 2016
Form
Liquide topique
Route of administration
Topique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Equisetum arvense

Source : Feuille

Extraction ratio : 2.5:1

Dry plant equivalent : 0.15 g

0.05 %
Equisetum arvense

Source : Tige

Extraction ratio : 2.5:1

Dry plant equivalent : 0.15 g

0.05 %
Méthylsulfonylméthane

Source : Sulfone de diméthyl

5 %

Non-medicinal ingredients

Ethoxydiglycol, Hydroxypropyl-chitosane, Ethanol, Eau purifiée, Propylène glycol

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedNot specified1 Tous les jours

Uses authorised in Canada

Helps relieve the symptoms of damaged nails such as splitting and fragility.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80033844

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2016. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line